参考文献

［1］张欣贺. 脉冲核磁共振成像实验仪原理及其应用［J］. 中国卫生产业，2015（20）：3.

［2］HAMOEN E H J，DE ROOIJ M，WITJES J A，et al. Use of the prostate imaging reporting and data system（PI-RADS）for prostate cancer detection with multiparametric magnetic resonance imaging：a diagnostic metaanalysis［J］. Eur Urol，2015，67：1112-1121.

［3］WEINREB J C，BARENTSZ J O，CHOYKE P L，et al. PI-RADS prostate imaging-reporting and data system：2015，version 2［J］. Eur Urol，2016，69：16-40.

［4］WOO S，SUH C H，KIM S Y，et al. Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer：a systematic review and diagnostic meta-analysis［J］. Eur Urol，2017，72：177-188.

［5］ZHANG L，TANG M，Chen S，et al. A meta-analysis of use of prostate imaging reporting and data system version 2（PI-RADS V2）with multiparametric MR imaging for the detection of prostate cancers［J］. Eur Urol，2017，27：5204-5214.

［6］TURKBEY B，ROSENKRANTZ A B，HAIDER M A，et al. Prostate imaging reporting and data system version 2. 1：2019 update of prostate imaging reporting and data system version 2［J］. Eur Urol，2019，76：340-351.

［7］AHDOOT M，WILBUR A R，REESE S E，et al. MRI-targeted，systematic，and combined biopsy for prostate cancer Diagnosis［J］. N Engl J Med，2020，382（10）：917-928.

［8］BARBIERI S，BRONNIMANN M，BOXLER S，et al. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI［J］. Eur Radiol，2017，27（4）：1547-1555.

［9］ZHANG Y D，WANG Q，WU C J，et al. The histogram analysis of diffusion-weighted intravoxel incoherent motion（IVIM）imaging for differentiating the gleason grade of prostate cancer［J］. Eur Radiol，2015，25（4）：994-1004.

［10］LIU X，ZHOU L，PENG W，et al. Comparison of stretched-exponential and monoexponential model diffusionweighted imaging in prostate cancer and normal tissues［J］. J Magn Reson Imaging，2015，42（4）：1078-1085.

［11］FUKUNAGA T，TAMADA T，KANOMATA N，et al. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T［J］. Magn Reson Imaging，2021，83：152-159.

［12］CRISTEL，GIULIA，ESPOSITO，et al. Can DCE-MRI reduce the number of PI-RADS v. 2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization［J］. Eur J Radiol，2019，118：51-57.

［13］PARK H，KIM S H，KIM J Y. Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer［J］. Quant Imaging Med Surg，2022，12（1）：742-751. aFFV9bj0qkxjr4CHsV7ifmXZV3b4mp2vAazpygSNR5rHrrX6MEDMPOC528Dc2o1w